重新设计试验以纳入学习障碍人群——一个实践示例
英国协作项目「没有我们参与,就不要做关于我们的研究」第三工作组以平台试验PANORAMIC为例,使用INCLUDE受损决策能力同意框架进行共同分析,识别纳入学习障碍人群的障碍并提出可扩大其参与的设计策略,如早期参与、修订入选标准、合理调整和简化流程。
要点
- 约三分之二的试验直接或间接排除学习障碍人群,加剧其健康不平等。
- 以PANORAMIC试验为例,学习障碍人群仅占招募者的0.01%。
- 使用INCLUDE框架共同分析,提出早期参与、修订标准、合理调整和简化流程等策略。
核心结论
- 为实现更好的健康公平并提高临床试验质量,研究人员必须更加关注可及的研究设计,并确保有适当的便利措施来纳入学习障碍人群。
研究设计与样本
- 英国协作项目「没有我们参与,就不要做关于我们的研究」第三工作组旨在产出如何重新设计试验以更包容学习障碍人群的实践示例。
- 重新设计过程包括三步:使用预设标准确定合适的试验、选择工具系统审查试验、识别障碍并提出可扩大参与的替代设计方法。
主要发现
- 审查资助方项目组合后,选择了一个平台试验(PANORAMIC),该试验曾试图将学习障碍人群作为COVID-19高风险群体纳入,但该人群仅占招募者的0.01%。
- 使用INCLUDE受损决策能力同意框架,共同分析识别出可确保更好纳入学习障碍人群的实用策略。
- 策略包括:在设计最早阶段让学习障碍人群参与、重新审视入选标准、进行合理调整(如所有文件提供高质量易读版本)以及简化过于复杂的研究流程。
临床怎么用
- 作者建议研究人员更加关注可及的研究设计,并确保有适当的便利措施来纳入学习障碍人群。
- 作者提出的实用策略包括:在设计最早阶段让学习障碍人群参与、重新审视入选标准、进行合理调整(如所有文件提供高质量易读版本)以及简化过于复杂的研究流程。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with a learning disability are frequently excluded from clinical trials, with around two thirds of trials either directly or indirectly excluding this group. This contributes to the shocking health inequalities they experience, with people with a learning disability having higher rates of long-term health conditions and dying on average 20 years younger than the general population. Improving inclusion of under-served groups in trials is a priority area for research funders and regulators. A UK-wide collaboration, 'No Research About Us, Without Us', was formed to explore and address the barriers to engaging and involving people with a learning disability in research. The project consisted of a number of intersecting work streams. This paper reports the findings from Working Group 3 which aimed to produce practical examples about how a trial could be redesigned to ensure it is more inclusive of people with a learning disability. METHODS: The redesign process consisted of three steps: (1) identifying an appropriate trial using predefined criteria, (2) selecting a tool to systematically review the trial, and (3) identifying barriers to inclusion of people with a learning disability and proposing alternative design approaches that could have widened access to the trial. RESULTS: Following review of a funder's portfolio, we selected a platform trial (PANORAMIC) which had sought to include people with a learning disability as a high-risk group for COVID-19 and yet had only made up 0.01% of those recruited. Using the INCLUDE Impaired Capacity to Consent Framework, our co-produced analysis identified practical strategies that could have ensured greater inclusion of people with a learning disability. This included involving people with a learning disability at the earliest design stage, revisiting eligibility criteria, making reasonable adjustments (e.g. high-quality easy read versions of all documents), and simplifying overly complex study processes. CONCLUSION: To achieve better health equity and improve the quality of clinical trials, researchers must pay greater attention to accessible study design and ensure appropriate accommodations are in place to enable inclusion of people with a learning disability. We outline some practical strategies that can inform the design and conduct of future trials to improve inclusion.
引用
- Shepherd V, Royston R, Totsika V, et al. Redesigning trials to be inclusive of people with a learning disability-a practical example. Trials. 2026. PMID: 41526988. doi:10.1186/s13063-026-09446-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。